India to Lebanon: Ibrutinib Export Trade Route

The India to Lebanon Ibrutinib corridor is one of India's established pharmaceutical export routes, with 18 shipments documented worth a combined $28.1K USD. The route is dominated by RMPL PHARMA LLP, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's ibrutinib manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $1.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with ibrutinib's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 25.4%, placing it at rank #9 among India's top ibrutinib export destinations globally.

On the import side, key buyers of Indian ibrutinib in Lebanon include TO THE ORDER OF INVOICE RAISED TO, TO THE ORDER OF INVOICE, ADVANCED TRADING SERVICES and 1 others. TO THE ORDER OF INVOICE RAISED TO is the single largest importer with 6 shipments valued at $11.0K USD.

India's ibrutinib exports to Lebanon are driven primarily by a handful of large-scale manufacturers. RMPL PHARMA LLP with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Lebanon benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — RMPL PHARMA LLP, TRIKAYA GLOBAL, SHIVNAAM TRADELINK LLP — together account for 100% of total trade value on this route. The average shipment value of $1.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ibrumed 140 mg (30 cap)(ibrutinib capsules) (100 packx30=3000 caps)nos and nitib 140mg (30cap) (ibrutinib capsules)(65 packx30=1950 caps), suggesting that buyers in Lebanon tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF INVOICE RAISED TO is the largest importer with 6 shipments worth $11.0K USD — representing 39% of all ibrutinib imports from India on this route.